Ambu A/S

CPSE:AMBU B Stock Report

Market Cap: DKK 16.6b

Ambu Future Growth

Future criteria checks 4/6

Ambu is forecast to grow earnings and revenue by 23.6% and 10.7% per annum respectively. EPS is expected to grow by 24.4% per annum. Return on equity is forecast to be 13.2% in 3 years.

Key information

23.6%

Earnings growth rate

24.41%

EPS growth rate

Medical Equipment earnings growth15.3%
Revenue growth rate10.7%
Future return on equity13.17%
Analyst coverage

Good

Last updated12 May 2026

Recent future growth updates

Analysis Article May 09

Ambu A/S Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next

As you might know, Ambu A/S ( CPH:AMBU B ) last week released its latest quarterly, and things did not turn out so...
Analysis Article Feb 08

Earnings Miss: Ambu A/S Missed EPS By 8.7% And Analysts Are Revising Their Forecasts

Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.3% to close at kr.87.90 following the...
Analysis Article Aug 27

Ambu A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.4% to close at kr.98.20 following the...

Recent updates

Analysis Article May 09

Ambu A/S Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next

As you might know, Ambu A/S ( CPH:AMBU B ) last week released its latest quarterly, and things did not turn out so...
Narrative Update May 04

AMBU B: Higher Growth And Margins Are Expected To Support Future Upside

Analysts have reduced their price target on Ambu by DKK 12. This reflects updated views on discount rates, expected revenue growth, profit margins and future P/E assumptions.
Narrative Update Apr 20

AMBU B: Reset P/E Assumptions Will Support Future Upside Repricing

Ambu's analyst price target has been reduced by DKK 12 to reflect updated views on its P/E assumptions, revenue growth profile and profitability, with analysts pointing to the recent DKK 12 target cut cited in Street research. Analyst Commentary JPMorgan's DKK 12 reduction in its Ambu price target reflects a reset of P/E expectations and a more cautious stance on the company's revenue growth and profitability profile.
Narrative Update Apr 06

AMBU B: Refined Discount Rate And P/E Expectations Will Support Future Upside

Analysts have lowered their price target on Ambu by DKK 12. This reflects small adjustments to fair value, discount rate, revenue growth, profit margin and future P/E assumptions following recent research updates.
Narrative Update Mar 22

AMBU B: Lower P/E Assumptions Will Support Upside If Execution Improves

Analysts have lowered their price target on Ambu by DKK 12 to reflect slightly adjusted assumptions on fair value, discount rate, revenue growth, profit margin, and future P/E following the recent JPMorgan target cut to DKK 12. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value and discount rate assumptions as a reset that could leave room for upside if Ambu delivers on its operational targets.
Narrative Update Mar 08

AMBU B: Share Repurchase Mandate And Lowered Fair Value Will Support Upside

Analysts have trimmed their price target on Ambu by DKK 12 to reflect updated assumptions on fair value, discount rates and earnings expectations following recent research commentary. Analyst Commentary Bullish Takeaways Bullish analysts view the revised DKK 12 lower price target as still consistent with a supportive fair value range.
Narrative Update Feb 22

AMBU B: Share Buybacks And Margin Discipline Will Support Future Upside

The analyst price target for Ambu has been trimmed by DKK 1 to DKK 138, as analysts factor in slightly more cautious assumptions on growth, margins and discount rates following recent price target adjustments, such as the DKK 12 cut highlighted by JPMorgan. Analyst Commentary Bullish analysts remain focused on how Ambu can justify its current valuation through consistent execution on its growth plans, even as some price targets, including the DKK 12 adjustment flagged by JPMorgan, are recalibrated.
Narrative Update Feb 08

AMBU B: Higher Risk Premium And Margin Pressure Will Reshape Share Outlook

The analyst price target for Ambu has been reduced from DKK 94.54 to DKK 78.00. This change reflects analysts’ updated assumptions on discount rate, revenue growth, profit margin and future P/E, as highlighted by recent Street research including a DKK 12 target cut.
Analysis Article Feb 08

Earnings Miss: Ambu A/S Missed EPS By 8.7% And Analysts Are Revising Their Forecasts

Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.3% to close at kr.87.90 following the...
Narrative Update Jan 25

AMBU B: Share Repurchases And Dividend Policy Will Support Future Upside

Analysts have slightly reduced their price target on Ambu, citing modest revisions to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Together, these changes support a more cautious yet still constructive view on the shares.
Narrative Update Jan 11

AMBU B: Share Buybacks And Dividend Policy Will Support Future Upside

Analysts now set Ambu's price target at €139, down from €147, citing updated assumptions for discount rates, revenue growth, profit margins and future P/E that adjust their valuation framework. What's in the News Ambu A/S is set to be removed from the OMX Copenhagen 20 Index, which may affect how some index and benchmark focused investors view or hold the stock (Key Developments).
Analysis Article Jan 03

Ambu A/S' (CPH:AMBU B) Price In Tune With Earnings

With a price-to-earnings (or "P/E") ratio of 37.7x Ambu A/S ( CPH:AMBU B ) may be sending very bearish signals at the...
Narrative Update Dec 19

AMBU B: Dividend And Share Buybacks Will Drive Future Upside Potential

Analysts have trimmed their price target for Ambu slightly, lowering fair value by about 1 dollar per share as modestly slower expected revenue growth and profit margins are only partly offset by a slightly higher future P/E multiple and lower discount rate. What's in the News Ambu has launched a new share repurchase program starting December 10, 2025, allowing buybacks of up to 10% of its share capital under a mandate valid until December 13, 2027 (company announcement) The company announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with an ex date of December 4 and record date of December 5, 2025 (company announcement) For fiscal 2025/26, Ambu issued guidance for 10% to 13% organic growth and an EBIT margin of 12% to 14%, or 14% to 16% excluding roughly 2 percentage points of tariff impacts (company guidance) Ambu reaffirmed its 2024/25 financial guidance, maintaining expectations for 12% to 14% organic revenue growth (company guidance) Valuation Changes Fair Value Estimate edged down slightly from DKK 115.59 to DKK 114.79 per share, reflecting a modestly lower fundamental valuation.
Analysis Article Dec 12

An Intrinsic Calculation For Ambu A/S (CPH:AMBU B) Suggests It's 34% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, Ambu fair value estimate is kr.130 Ambu's kr.85.60 share price...
Narrative Update Dec 05

AMBU B: Dividend Initiation And Margin Outlook Will Support Future Upside

Analysts have modestly raised their price target on Ambu by DKK 0.00 to reflect a slightly higher discount rate and updated profitability assumptions, while maintaining largely unchanged views on long term growth and valuation multiples. What's in the News Ambu A/S announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with ex-date December 4 and record date December 5, 2025 (Key Developments).
Analysis Article Nov 27

We Think Shareholders Are Less Likely To Approve A Pay Rise For Ambu A/S' (CPH:AMBU B) CEO For Now

Key Insights Ambu's Annual General Meeting to take place on 3rd of December Salary of kr.8.01m is part of CEO Britt...
Narrative Update Nov 21

AMBU B: Improved Margins And Dividend Outlook Will Support Bullish Momentum

Analysts have slightly lowered their fair value price target for Ambu from DKK 121.41 to DKK 115.59, citing modest decreases in projected revenue growth and profit margin expectations. What's in the News Ambu A/S announced an annual dividend of DKK 0.4100 per share.
Narrative Update Nov 06

AMBU B: Higher Profit Margins Will Drive Hospital Efficiency Improvements

Analysts have revised their fair value estimate for Ambu down from DKK 130.70 to DKK 121.41. They cite a slightly higher discount rate, even though profit margin and revenue growth projections have improved.
Analysis Article Oct 07

Ambu (CPH:AMBU B) Has More To Do To Multiply In Value Going Forward

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
Analysis Article Aug 27

Ambu A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.4% to close at kr.98.20 following the...
Analysis Article Aug 11

Is Ambu A/S (CPH:AMBU B) Trading At A 35% Discount?

CPSE:AMBU B 1 Year Share Price vs Fair Value Explore Ambu's Fair Values from the Community and select yours Key...
Analysis Article Jul 12

Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?

Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it saw significant share price movement during...
Analysis Article May 15

Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye

The stock was sluggish on the back of Ambu A/S' ( CPH:AMBU B ) recent earnings report. We have done some analysis, and...
Analysis Article Mar 14

Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Analysis Article Feb 02

Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts

Ambu A/S ( CPH:AMBU B ) last week reported its latest quarterly results, which makes it a good time for investors to...
Analysis Article Jan 27

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Analysis Article Jan 12

Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%

Ambu A/S ( CPH:AMBU B ) shareholders would be excited to see that the share price has had a great month, posting a 27...
Analysis Article Dec 31

Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?

Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it received a lot of attention from a substantial...
User avatar
New Narrative Dec 16

Innovative aScope 5 Uretero And Sustainable Initiatives Will Accelerate Revenue Growth

Strategic focus on new high-value product launches and sustainability efforts could enhance revenue growth, product adoption, and brand perception while supporting long-term profitability.
Analysis Article Nov 28

Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year

Key Insights Ambu will host its Annual General Meeting on 4th of December CEO Britt Jensen's total compensation...
Analysis Article Nov 13

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Ambu A/S ( CPH:AMBU B ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests that...
Analysis Article Nov 07

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Shareholders might have noticed that Ambu A/S ( CPH:AMBU B ) filed its full-year result this time last week. The early...
Analysis Article Sep 02

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

It's been a sad week for Ambu A/S ( CPH:AMBU B ), who've watched their investment drop 10% to kr.128 in the week since...
Analysis Article Aug 06

Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
Analysis Article Apr 06

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

With a median price-to-sales (or "P/S") ratio of close to 6.1x in the Medical Equipment industry in Denmark, you could...
Analysis Article Mar 14

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...
Analysis Article Feb 01

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 2.9% to close at kr.115 following the release...
Analysis Article Jan 02

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

It's not a stretch to say that Ambu A/S' ( CPH:AMBU B ) price-to-sales (or "P/S") ratio of 5.9x right now seems quite...
Analysis Article Oct 31

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Key Insights Ambu's estimated fair value is kr.114 based on 2 Stage Free Cash Flow to Equity Ambu's kr.66.00 share...

Earnings and Revenue Growth Forecasts

CPSE:AMBU B - Analysts future estimates and past financials data (DKK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20287,9871,0538421,2978
9/30/20277,1818116381,1028
9/30/20266,4546055189498
3/31/20266,104477375847N/A
12/31/20256,085544351753N/A
9/30/20256,037609407791N/A
6/30/20255,958359375735N/A
3/31/20255,834370410733N/A
12/31/20245,647326458768N/A
9/30/20245,391235524813N/A
6/30/20245,263450614893N/A
3/31/20245,075367608902N/A
12/31/20234,897238501805N/A
9/30/20234,775168192518N/A
6/30/20234,679-42-168217N/A
3/31/20234,612-65-318119N/A
12/31/20224,54595-47525N/A
9/30/20224,44493-46395N/A
6/30/20224,307222-401185N/A
3/31/20224,152256-521107N/A
12/31/20214,031176-419194N/A
9/30/20214,013247-256328N/A
6/30/20213,858251-187347N/A
3/31/20213,832281111593N/A
12/31/20203,82029056511N/A
9/30/20203,567241-135295N/A
6/30/20203,302146-24366N/A
3/31/20203,128270-62277N/A
12/31/20192,924296N/A330N/A
9/30/20192,820317N/A533N/A
6/30/20192,943515N/A597N/A
3/31/20192,843411N/A553N/A
12/31/20182,709372N/A560N/A
9/30/20182,606337N/A554N/A
6/30/20182,506318N/A498N/A
3/31/20182,434288N/A456N/A
12/31/20172,396281N/A476N/A
9/30/20172,355301N/A462N/A
6/30/20172,299306N/A403N/A
3/31/20172,215299N/A460N/A
12/31/20162,134267N/A420N/A
9/30/20162,084250N/A369N/A
6/30/20162,047224N/A408N/A
3/31/20162,012169N/A269N/A
12/31/20151,963175N/A246N/A
9/30/20151,889152N/A208N/A
6/30/20151,795171N/A141N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AMBU B's forecast earnings growth (23.6% per year) is above the savings rate (2%).

Earnings vs Market: AMBU B's earnings (23.6% per year) are forecast to grow faster than the Danish market (9% per year).

High Growth Earnings: AMBU B's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AMBU B's revenue (10.7% per year) is forecast to grow faster than the Danish market (3.7% per year).

High Growth Revenue: AMBU B's revenue (10.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: AMBU B's Return on Equity is forecast to be low in 3 years time (13.2%).


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/13 14:12
End of Day Share Price 2026/05/13 00:00
Earnings2026/03/31
Annual Earnings2025/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ambu A/S is covered by 14 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Michael HealyBerenberg
Susannah LudwigBernstein